Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation
Open accessThe DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Inhibitors of the mitochondrial respiratory chain complex I are suggested to exert anti-tumor activity on those tumors relying on oxidative metabolism and are therefore of interest to oncology research. Nevertheless, the safety profile of these inhibitors should be thoroughly assessed. Rotenone, a proven complex I inhibitor, has shown anti-carcinogenic activity in several studies. In this context rotenone was used in this study as a tool compound with the aim to identify suitable biomarker candidates and provide enhanced mechanistic insights into the molecular and cellular effects of complex I inhibitors. Rats were treated with 400 ppm rotenone daily for 1, 3 or 14 consecutive days followed by necropsy. Classical clinical endpoints, including hematology, clinical chemistry and histopathology with supporting investigations (FACS-analysis, enzymatic activity assays) were examined as well as gene expression analysis. Through these investigations, we identified liver, bone marrow and bone as target organs amongst approx. 40 organs evaluated at least histopathologically. Our results suggest blood analysis, bone marrow parameters, assessment of lactate in serum and glycogen in liver, and especially gene expression analysis in liver as useful parameters for an experimental model to help to characterize the profile of complex I inhibitors with respect to a tolerable risk-benefit balance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Rotenone acts as a strong inhibitor of complex I of the ETC [415,416,417].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [415]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
U.S. Department of Health and Human Services
(2006) · Encyclopedia of Sexual Behavior and the Law · doi:10.4135/9781452240107.n226 · Cited by 3,170
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., & Robinson, J. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210432200 · Cited by 1,433
Research works printed but not linked: 4
- OJEU. Official Journal of European Union. Commission Decision of 8 December 2008 concerning the non-inclusion of certain active substances in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing these substances. L 335/91.13.12.2008. (2008c).
- Losco, P. In Pathobiology of the Aging Rat Vol. 1 (eds U. Mohr, D. L. Dungworth & C. C. Capen ) Ch. 75-94, (ILSI Press, 1992).
- Fernández-Vizarra, E., Fernández-Silva, P. & Enríquez, J. A. In Cell Biology: A Laboratory Handbook Vol. 2 (ed J. E. Celis ) Ch. 10, 69–77 (2006).
- Paxinos, G. & Watson, C. The rat brain in stereotaxic coordinates. 3rd edn, (Academic Press, 1997).
Cited by
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Molecular mechanisms of environmental exposures and human disease
Wu, H., Eckhardt, C. M., & Baccarelli, A. A. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00569-3 · Cited by 273
Metabolic reprogramming in prostate cancer
Ahmad, F., Cherukuri, M. K., & Choyke, P. L. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01435-5 · Cited by 212
Mitochondrial Reactive Oxygen Species and Mitophagy: A Complex and Nuanced Relationship
Schofield, J. H., & Schafer, Z. T. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8058 · Cited by 204
Environmental Chemical Exposures and Mitochondrial Dysfunction: a Review of Recent Literature
Reddam, A., McLarnan, S., & Kupsco, A. (2022) · Current Environmental Health Reports · doi:10.1007/s40572-022-00371-7 · Cited by 190
Kujawska, M., Jourdes, M., Kurpik, M., Szulc, M., Szaefer, H., Chmielarz, P., Kreiner, G., Krajka-Kuźniak, V., Mikołajczak, P. Ł., Teissedre, P.-L., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010202 · Cited by 159
Tumour metabolism and its unique properties in prostate adenocarcinoma
Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 179
Kung, H., Lin, K.-J., Kung, C., & Lin, T. (2021) · Biomedicines · doi:10.3390/biomedicines9080918 · Cited by 180
Rotenone: from modelling to implication in Parkinson’s disease
Radad, K., Al-Shraim, M. M., Al‐Emam, A., Wang, F., Kranner, B., Rausch, W., & Moldzio, R. (2019) · Folia Neuropathologica · doi:10.5114/fn.2019.89857 · Cited by 141
Using Rotenone to Model Parkinson’s Disease in Mice: A Review of the Role of Pharmacokinetics
Innos, J., & Hickey, M. A. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00522 · Cited by 145
Mitochondrial complex I as a therapeutic target for Alzheimer's disease
Trushina, E. V., Trushin, S., & Hasan, M. F. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.003 · Cited by 141
Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
Lee, M., Hirpara, J. L., Eu, J.-Q., Sethi, G., Wang, L., Goh, B.-C., & Wong, A. L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101073 · Cited by 127
Mitochondria as a target in cancer treatment
Liu, Y., & Shi, Y. (2020) · MedComm · doi:10.1002/mco2.16 · Cited by 130
The coupling mechanism of mammalian mitochondrial complex I
Gu, J., Liu, T., Guo, R., Zhang, L., & Yang, M. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00722-w · Cited by 107
Aw, W. C., Towarnicki, S. G., Melvin, R. G., Youngson, N. A., Garvin, M. R., Hu, Y., Nielsen, S., Thomas, T., Pickford, R., Bustamante, S., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007735 · Cited by 101
The role of microRNAs in bone development
Bell‐Hensley, A., & McAlinden, A. (2020) · Bone · doi:10.1016/j.bone.2020.115760 · Cited by 99
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 87
Motawi, T. K., Al-Kady, R. H., Abdelraouf, S. M., & Senousy, M. A. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110002 · Cited by 88
Sun, Q., Liu, Q., Zhou, X., Wang, X., Li, H., Zhang, W., Yuan, H., & Sun, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106419 · Cited by 93
Mitochondrial metabolism as a target for acute myeloid leukemia treatment
Panina, S., Pei, J., & Kirienko, N. V. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00253-w · Cited by 88
The hidden side of Parkinson’s disease: Studying pain, anxiety and depression in animal models
Faivre, F., Joshi, A., Bézard, E., & Barrot, M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.004 · Cited by 80
Morais, L. H., Hara, D. B., Bicca, M. A., Poli, A., & Takahashi, R. N. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000389 · Cited by 58
Metabolic adaptations in prostate cancer
Pujana-Vaquerizo, M., Bozal‐Basterra, L., & Carracedo, A. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02762-z · Cited by 98
Burns, J. E., Hurst, C. D., Knowles, M. A., Phillips, R. M., & Allison, S. J. (2021) · Cancer Science · doi:10.1111/cas.15047 · Cited by 82
Integrated view of plant metabolic defense with particular focus on chewing herbivores
Wari, D., Aboshi, T., Shinya, T., & Gális, I. (2021) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13204 · Cited by 78
Bhatti, G. K., Gupta, A., Pahwa, P., Khullar, N., Singh, S., Navik, U., Kumar, S., Mastana, S. S., Reddy, A. P., Reddy, P. H., et al. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.05.002 · Cited by 78
Cox, M. J., Jaensch, S., de Waeter, J. V., Cougnaud, L., Seynaeve, D., Benalla, S., Koo, S. J., den Wyngaert, I. V., Neefs, J., Malkov, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69354-8 · Cited by 80
Engine shutdown: migrastatic strategies and prevention of metastases
Raudenská, M., Petrláková, K., Juriňáková, T., Fialová, J. L., Fojtů, M., Jakubek, M., Rösel, D., Brábek, J., & Masařík, M. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.01.001 · Cited by 74
Cabezas, R., Báez-Jurado, E., Hidalgo‐Lanussa, O., Echeverría, V., Ashrad, G. M., Sahebkar, A., & Barreto, G. E. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1203-9 · Cited by 67
Microenvironmental stiffness induces metabolic reprogramming in glioblastoma
Sohrabi, A., Lefebvre, A. E. Y. T., Harrison, M. J., Condro, M. C., Sanazzaro, T., Safarians, G., Solomon, I., Bastola, S., Kordbacheh, S., Toh, N., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113175 · Cited by 73
OXPHOS inhibitors, metabolism and targeted therapies in cancer
Cadassou, O., & Jordheim, L. P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115531 · Cited by 59
Michl, J., Wang, Y., Monterisi, S., Błaszczak, W., Beveridge, R. D. D., Bridges, E., Koth, J., Bodmer, W. F., & Swietach, P. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110493 · Cited by 60
Mohammed, N. N., Tadros, M. G., & George, M. Y. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01384-w · Cited by 64
Marino, A., Battaglini, M., Desii, A., Lavarello, C., Genchi, G. G., Petretto, A., & Ciofani, G. (2021) · Biomaterials Science · doi:10.1039/d1bm01202a · Cited by 62
Chouhan, S., Sawant, M., Weimholt, C., Luo, J. R., Sprung, R. W., Terrado, M., Mueller, D. M., Earp, H. S., & Mahajan, N. P. (2022) · Autophagy · doi:10.1080/15548627.2022.2103961 · Cited by 60
Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
Бунеева, О. А., Fedchenko, V. I., Kopylov, A. T., & Medvedev, A. E. (2020) · Biomedicines · doi:10.3390/biomedicines8120591 · Cited by 66
Júnior, O. V. R., Alves, B. D. S., Barros, P. A. B., Rodrigues, J. L., Ferreira, S. P., Monteiro, L. K. S., Araújo, G. D. M. S., Fernandes, S. S., Vaz, G. R., Dora, C. L., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00362-w · Cited by 58
Datta, S., He, G., Tomilov, A. A., Sahdeo, S., Denison, M. S., & Cortopassi, G. A. (2017) · Environmental Health Perspectives · doi:10.1289/ehp1404 · Cited by 56
Tyrrell, D. J., Blin, M. G., Song, J., Wood, S. C., & Goldstein, D. R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017820 · Cited by 52
Noble, R. A., Thomas, H. D., Zhao, Y., Herendi, L., Howarth, R., Dragoni, I., Keun, H. C., Vellano, C. P., Marszalek, J. R., & Wedge, S. R. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01848-w · Cited by 58
Amoêdo, N. D., Sarlak, S., Obre, É., Estèves, P., Bégueret, H., Kieffer, Y., Rousseau, B., Alexis, D., Izotte, J., Bellancé, N., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci133081 · Cited by 58
Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Pinilla, L. L., Ugun‐Klusek, A., Rutella, S., & Girolamo, L. A. D. (2021) · Biology · doi:10.3390/biology10080723 · Cited by 59
Li, Z., Wang, Z., Tang, Y., Lu, X., Chen, J., Dong, Y., Wu, B., Wang, C., Liu, Y., Guo, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11808-3 · Cited by 52
Millichap, L. E., Damiani, E., Tiano, L., & Hargreaves, I. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111444 · Cited by 50
Extrapolating from acute to chronic toxicity in vitro
Macko, P., Palosaari, T., & Whelan, M. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105206 · Cited by 51
Approaches to monitor ATP levels in living cells: where do we stand?
Ley‐Ngardigal, S., & Bertolin, G. (2021) · FEBS Journal · doi:10.1111/febs.16169 · Cited by 52
Rotenone causes mitochondrial dysfunction and prevents maturation in porcine oocytes
Heo, G., Sun, M., Jiang, W., Li, X., Lee, S., Guo, J., Zhou, D., & Cui, X.-S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277477 · Cited by 49
Chamoli, M., Rane, A., Foulger, A., Chinta, S. J., Shahmirzadi, A. A., Kumsta, C., Nambiar, D. K., Hall, D., Holcom, A., Angeli, S., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00524-9 · Cited by 48
Targeted DNA oxidation by LSD1–SMAD2/3 primes TGF-β1/ EMT genes for activation or repression
Pezone, A., Taddei, M. L., Tramontano, A., Dolcini, J., Boffo, F. L., Rosa, M. D., Parri, M., Stinziani, S., Comito, G., Porcellini, A., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa599 · Cited by 47
Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation
Özbey, G., Samur, D. N., Parlak, H., Yıldırım, S., Aslan, M., Tanrιöver, G., & Ağar, A. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00095-1 · Cited by 40
Lai, B., Bernhardt, P. V., & Krömer, J. O. (2020) · ChemSusChem · doi:10.1002/cssc.202001645 · Cited by 41
Zhou, Y., Zou, J., Xu, J. B., Zhou, Y., Cen, X., & Zhao, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115219 · Cited by 45
Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification
Chen, W., Liu, J., Zheng, C., Bai, Q., Gao, Q., Zhang, Y., Dong, K., & Lu, T. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s366187 · Cited by 42
Trigo, D., Nadais, A., Carvalho, A. L. N., Morgado, B., dos Santos, F., Pereira, S. N., & Silva, O. A. B. D. C. E. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.10.002 · Cited by 40
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
Panina, S., Pei, J., Baran, N., Konopleva, M. Y., & Kirienko, N. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00435 · Cited by 37
Pradhan, S. H., Mulenos, M. R., Steele, L. R., Gibb, M., Ede, J. D., Ong, K. J., Shatkin, J. A., & Sayes, C. M. (2020) · Toxicology Research · doi:10.1093/toxres/tfaa026 · Cited by 37
Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells
Shen, Y., Chen, C.-C., Chen, B., Wu, Y.-T., Juan, J.-R., Chen, L.-Y., Teng, Y.-C., & Wei, Y. (2021) · Cells · doi:10.3390/cells10071772 · Cited by 41
Xiao, H., Han, B., Zhao, Y., Li, G., Wang, T., He, J., Du, W., Cao, X., Gan, J., Wang, Z., et al. (2022) · Nutrients · doi:10.3390/nu14173508 · Cited by 46
Alrubayyi, A., Cubero, E. M., Hameiri‐Bowen, D., Matthews, R., Rowland‐Jones, S., Schurich, A., & Peppa, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908697 · Cited by 43
Choudhary, N., Choudhary, S., Kumar, A., & Singh, V. (2020) · Gene · doi:10.1016/j.gene.2020.145385 · Cited by 41
Chen, M., Chen, Y., Zhu, W., Yan, X., Jing, X., Zhang, P., Liu, P., & Li, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115088 · Cited by 37
Akinmoladun, A. C., Olaniyan, O. O., Famusiwa, C. D., Josiah, S. S., & Olaleye, M. T. (2020) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2018-0230 · Cited by 36
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
Taghizadeh‐Hesary, F., Houshyari, M., & Farhadi, M. R. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04592-7 · Cited by 37
Akinade, T. C., Babatunde, O. O., Adedara, A. O., Adeyemi, O., Otenaike, T. A., Ashaolu, O. P., Johnson, T. O., Terriente-Félix, A., Whitworth, A. J., & Abolaji, A. O. (2022) · Scientific Reports · doi:10.1038/s41598-022-08409-4 · Cited by 35
Jain, J., Hasan, W., Biswas, P., Yadav, R. S., & Jat, D. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23165 · Cited by 36
Sastre‐Serra, J., Ahmiane, Y., Roca, P., Oliver, J., & Pons, D. G. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1540558 · Cited by 35
Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow
Buschhaus, J. M., Humphries, B. A., Eckley, S. S., Robison, T. H., Cutter, A. C., Rajendran, S., Haley, H. R., Bevoor, A. S., Luker, K. E., & Luker, G. D. (2020) · Oncogene · doi:10.1038/s41388-020-01391-z · Cited by 36
Lu, J., Chen, S., Shen, M., He, Q., Zhang, Y., Shi, Y., Ding, F., & Zhang, Q. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.09.031 · Cited by 35
Heishima, K., Sugito, N., Soga, T., Nishikawa, M., Ito, Y., Honda, R. P., Kuranaga, Y., Sakai, H., Ito, R., Nakagawa, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139933 · Cited by 36
Ujvari, B., Pytel, B., Márton, Z., Bognár, M. A., Kovács, L. Á., Farkas, J. I., Gaszner, T., Berta, G., Kecskés, A., Kormos, V., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02399-w · Cited by 35
Jain, R., Begum, N., Rajan, S., Tryphena, K. P., & Khatri, D. K. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.11.007 · Cited by 35
Desa, D. E., Nichols, M. G., & Smith, H. J. (2018) · Journal of Biomedical Optics · doi:10.1117/1.jbo.24.5.051403 · Cited by 37
Macedo, G. E., Vieira, P. D. B., Rodrigues, N. R., Gomes, K. K., Martins, I. K., Franco, J. L., & Posser, T. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111232 · Cited by 35
Kujawska, M., Jourdes, M., Witucki, Ł., Karaźniewicz‐Łada, M., Szulc, M., Górska, A., Mikołajczak, P. Ł., Teissèdre, P., & Jodynis‐Liebert, J. (2021) · Brain Sciences · doi:10.3390/brainsci11091127 · Cited by 32
Khot, M., Sood, A., Tryphena, K. P., Pinjala, P., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148462 · Cited by 33
Melatonin-Loaded Nanoparticles Augment Mitophagy to Retard Parkinson’s Disease
Biswal, L., Sardoiwala, M. N., Kushwaha, A. C., Mukherjee, S., & Karmakar, S. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c17092 · Cited by 31
Bao, Y. W., Hu, C., Wang, B., Liu, X., Wu, Q., Xu, D., Shi, Z., & Sun, C. (2025) · Biology · doi:10.3390/biology14091140 · Cited by 42
Demarque, D. P., & Espíndola, L. S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.779049 · Cited by 31
Lozoya, O. A., Xu, F., Grenet, D., Wang, T., Grimm, S. A., Godfrey, V., Waidyanatha, S., Woychik, R. P., & Santos, J. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108131 · Cited by 29
Guo, L., Zhang, W., Xie, Y., Chen, X., Olmstead, E. E., Lian, M., Zhang, B., Zaytseva, Y. Y., Evers, B. M., Spielmann, H. P., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0925 · Cited by 33
Palanisamy, B. N., Sarkar, S., Malovic, E., Samidurai, M., Charli, A., Zenitsky, G. D., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106225 · Cited by 29
Targeting mitochondrial transporters and metabolic reprogramming for disease treatment
Anselme, M., He, H., Lai, C., Luo, W., & Zhong, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06976-4 · Cited by 36
Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML
Caplan, M., Wittorf, K. J., Weber, K. K., Swenson, S. A., Gilbreath, T. J., Hynes-Smith, R. W., Amador, C. C., Hyde, R. K., & Buckley, S. M. (2022) · Leukemia · doi:10.1038/s41375-022-01518-z · Cited by 34
Triarylphosphine-Coordinated Bipyridyl Ru(II) Complexes Induce Mitochondrial Dysfunction
Mitchell, R. J., Gowda, A. S., Olivelli, A. G., Huckaba, A. J., Parkin, S., Unrine, J. M., Oza, V. D., Blackburn, J. S., Ladipo, F. T., Heidary, D. K., et al. (2023) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c00736 · Cited by 30
Rotenone protects against β-cell apoptosis and attenuates type 1 diabetes mellitus
Wu, M., Chen, W., Zhang, S., Huang, S., Zhang, A., Zhang, Y., & Jia, Z. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01566-4 · Cited by 28
Cuomo, P., Papaianni, M., Sansone, C., Iannelli, A., Iannelli, D., Medaglia, C., Paris, D., Motta, A., & Capparelli, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218369 · Cited by 30
Mun, Y., Kim, J., Choi, Y., & Lee, B. (2025) · Antioxidants · doi:10.3390/antiox14111276 · Cited by 37
Siima, A. A., Stephano, F., Munissi, J. J. E., & Nyandoro, S. S. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.09.004 · Cited by 27
Mursaleen, L., Noble, B., Somavarapu, S., & Zariwala, M. G. (2021) · Antioxidants · doi:10.3390/antiox10060887 · Cited by 29
Rajan, S., Sood, A., Jain, R., Tryphena, K. P., & Khatri, D. K. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137596 · Cited by 28
DJ-1 Protein and Its Role in the Development of Parkinson’s Disease: Studies on Experimental Models
Бунеева, О. А., & Medvedev, A. E. (2021) · Biochemistry (Moscow) · doi:10.1134/s000629792106002x · Cited by 26
Mitochondrial signaling pathways and their role in cancer drug resistance
Sharma, A., Virmani, T., Kumar, G., Sharma, A., Virmani, R., Gugulothu, D. B., Singh, K., Misra, S. K., Pathak, K., Chitranshi, N., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111329 · Cited by 32
Reactive oxygen species prevent lysosome coalescence during PIKfyve inhibition
Saffi, G. T., Tang, E., Inpanathan, S., Mammad, S., Fountain, A., Salmena, L., & Botelho, R. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259313 · Cited by 26
NADPH Oxidases in Neurodegenerative Disorders: Mechanisms and Therapeutic Opportunities
Fiadeiro, M. B., Diogo, J. C., Silva, A., Kim, Y., & Cristóvão, A. C. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0002 · Cited by 25
Mitochondrial DNA Haplotypes as Genetic Modifiers of Cancer
Tasdogan, A., McFadden, D. G., & Mishra, P. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.08.004 · Cited by 25
Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry
Kemble, S., Dalby, A., Lowe, G., Nicolson, P. L. R., Watson, S. P., Senis, Y. A., Thomas, S. G., & Harrison, P. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006073 · Cited by 23
Neurotoxic and behavioral deficit in Drosophila melanogaster co-exposed to rotenone and iron
Adedara, A. O., Otenaike, T. A., Olabiyi, A. A., Adedara, I. A., & Abolaji, A. O. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01104-3 · Cited by 25
Buck, S. A., Erickson-Oberg, M. Q., Bhatte, S. H., McKellar, C., Ramanathan, V. P., Rubin, S. A., & Freyberg, Z. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00741 · Cited by 24
Patikas, N., Ansari, R., & Metzakopian, E. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.06.001 · Cited by 28
Identification of In Vitro Inhibitors of Monkeypox Replication
Chiem, K., Nogales, A., Lorenzo, M. M., Vasquez, D. M., Xiang, Y., Gupta, Y. K., Blasco, R., de la Torre, J. C., & Martínez‐Sobrido, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04745-22 · Cited by 22
Metadata
- Authors
- Heinz, S., Freyberger, A., Lawrenz, B., Schladt, L., Schmuck, G., & Ellinger-Ziegelbauer, H.
- Affiliations
- Bayer (Germany) (DE)
- Corresponding author
- Ellinger-Ziegelbauer, Heidrun
- Venue
- Scientific Reports
- Published
- 2017-04-04
- Volume
- 7
- Issue
- 1
- Pages
- 45465-45465
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5379642
- OpenAlex
- W2604140695
- Cited by
- 334
- References
- 72
- Citations by year
- 2026: 33 · 2025: 48 · 2024: 43 · 2023: 62 · 2022: 45 · 2021: 42 · 2020: 31 · 2019: 16 · 2018: 12 · 2017: 2
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- rotenone, mitochondrial complex I inhibitors, electron transport chain, anticancer agents, oxidative metabolism, safety assessment, biomarkers, bone marrow, bone, histopathology, gene expression, lactate, glycogen
- MeSH terms
- Administration, Oral, Animals, Body Weight, Bone and Bones, Brain, Hematopoiesis, Liver, Male, Mitochondria, Rotenone, Gene Expression, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.